< Back to the Blog

About the author

Amy Divaraniya
Dr. Aparna (Amy) Divaraniya is the Founder and CEO of Oova. She has over 10 years experience working in data science and a PhD in Biomedical Sciences. In 2017, Amy pivoted to women's healthcare after facing her own fertility struggles. Amy started Oova to give women control over their fertility by making high-quality hormone testing more accessible.

Sources

  1. American Society for Reproductive Medicine. Fertility evaluation of infertile women: A committee opinion. Fertility and Sterility. 2021;116:1255-1265.
  2. American Society for Reproductive Medicine. Optimizing natural fertility: A committee opinion. Fertility and Sterility. 2022.
  3. Newman MR, et al. Comparison of day-specific serum LH, estradiol, and progesterone with urinary LH, E3G, and PdG levels in ovulatory cycles. 2024. Small exploratory comparison involving four serum-tracked cycles and three urine-tracked cycles.
  4. Blackwell LF, et al. Variability of normal menstrual-cycle profiles measured through urinary estrone glucuronide and pregnanediol glucuronide. Human Reproduction. 2013;28(12):3306-3315.
  5. Zeleznik AJ, Pohl CR. The neurosteroid progesterone underlies estrogen positive feedback of the LH surge. Endocrinology. 2012.

About the Oova Blog:
Our content is developed with a commitment to high editorial standards and reliability. We prioritize referencing reputable sources and sharing where our insights come from. The Oova Blog is intended for informational purposes only and is never a substitute for professional medical advice. Always consult a healthcare provider before making any health decisions.